We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Artificial Intelligence Methods Could Replace Histochemical Staining

By LabMedica International staff writers
Posted on 02 Nov 2022

In the hospital, there is a group of doctors who use tissue samples as "evidence materials", analyze the evidence using knives, slicers and microscopes to extract clues from the tissue samples, and provide patients with "verdicts" - diagnostic reports. More...

They are called the "judges" of the hospital - the pathologists. Pathologists observe the samples by staining them first. However, the standard procedures for staining tissue samples in histopathology are time-consuming and require specialized laboratory infrastructure, chemical reagents, and skilled technicians. Uncertainty in tissue staining in the handling of different laboratories and histology technicians may lead to misdiagnosis. In addition, the original tissue sample is not preserved by these histochemical staining techniques currently in use since each step of the procedures has irreversible impact on the sample.

With the advancement of artificial intelligence (AI), researchers are using AI techniques to improve pathology workflow. A recent study by researchers at the University of California Los Angeles (UCLA, Los Angeles, CA, USA) used deep neural networks to virtually stain microscopic images of unlabeled tissue. Deep neural networks have already been applied to stain unlabeled tissue section images, avoiding different laborious and time-consuming histochemical staining processes. There are, however, some bottlenecks. The most widely used autofocusing method demand many focus points across the tissue slide area with high focusing precision, and the best focal plane is determined by an iterative search algorithm, which is time consuming and may introduce photodamage and photobleaching on the samples.

To overcome these problems, the researchers presented a new deep learning-based fast virtual staining framework. Compared to the standard virtual staining framework, the new framework demonstrated by the researchers uses fewer focal points and reduces the focusing precision for each focus point to acquire coarsely-focused whole slide autofluorescence images of tissue. The new virtual staining framework can significantly reduce the time for autofocusing and the entire image acquisition process. Despite loss of image sharpness and contrast compared to standard virtual staining frameworks, high quality staining can still be produced, closely matching the corresponding histochemically stained ground truth images. Furthermore, this framework can also be used as an add-on module to improve the robustness of the standard virtual staining framework. This fast virtual staining framework will have more development prospects in the future.

“This framework uses an autofocusing neural network (termed Deep-R) to digitally refocus the defocused autofluorescence images. Then a virtual staining network is used to transform the refocused images into virtually stained images,” wrote the authors. “The deep learning-based framework decreases the total image acquisition time needed for virtual staining of a label-free whole slide images (WSI) by ~32%, also resulting in a ~89% decrease in the autofocusing time per tissue slide.”

“This fast virtual staining workflow can also be expanded to many other stains, such as Masson's Trichrome stain, Jones' silver stain, and immunohistochemical (IHC) stains,” the authors concluded. “Although the virtual staining approach presented here was demonstrated based on the autofluorescence imaging of unlabeled tissue sections, it can also be used to speed up the virtual staining workflow of other label-free microscopy modalities.”

Related Links:
UCLA


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New findings demonstrate a blood RNA signal that may indicate ovarian cancer before conventional tests detect a tumor. (Image Credit: iStock)

Blood RNA Test May Detect Precursors to Ovarian Cancer

High-grade serous ovarian cancer is often diagnosed at an advanced stage, limiting opportunities for early intervention. The disease frequently originates in the fallopian tube as serous tubal intraepithelial... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.